Development of a nucleotide precursor incorporation assay for testing drug sensitivity of human tumors.
D000970:Antineoplastic Agents / Q000633:toxicity*; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004261:DNA Replication / Q000187:drug effects*; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000378:metabolism / Q000473:pathology*; D009711:Nucleotides / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000378:metabolism / Q000473:pathology; D013736:Testicular Neoplasms / Q000378:metabolism / Q000473:pathology; D014158:Transcription, Genetic / Q000187:drug effects*
D000970:Antineoplastic Agents; D009711:Nucleotides